Comprehensive market analysis of Sofosbuvir (Sovaldi) in the USA, covering FDA approvals, patents, exclusivity, clinical insights, and strategic recommendations for market entry.

Comprehensive analysis of Inclisiran in the USA, covering FDA approvals, patents, clinical results, regulatory exclusivity, and strategic insights for innovators and potential generic challengers.

Comprehensive market analysis of Dobutamine Hydrochloride in the USA, including FDA approvals, patent barriers, clinical data, regulatory risks, and strategic recommendations for generic manufacturers.

Explore the US market analysis of Lacosamide, including FDA approvals, patent landscape, clinical results, regulatory risks, and strategic recommendations for generic and innovator companies.

Discover the global market landscape of Amisulpride, including patent barriers, clinical insights, regulatory risks, and strategic opportunities in the US, China, and EU markets.

Explore the latest FDA & China-approved drugs in June 2025, including Genakumab (gout), Taletrectinib (NSCLC), and Clesrovimab (RSV). Key clinical benefits & market impact.

Explore how CSPC ($5B deal), Sanofi, and Eli Lilly invested $12B+ in AI drug discovery, RNA editing & in vivo CAR-T in May 2025.

In May 2025, the global pharmaceutical landscape witnessed a wave of innovation.

In April 2025, a series of innovative drugs targeting various disease areas received regulatory approval, ranging from rare diseases.

Explore the booming mRNA therapeutics market, projected to exceed USD 100 billion by 2028. Learn how mRNA drugs work, their key advantages, and the global leaders driving innovation in vaccines and cancer treatment.

Nav1.8 inhibitors represent a breakthrough in pain therapeutics, offering a non-addictive alternative to opioids.

Explore the safety challenges of ASO drugs, and learn how chemical modifications and targeted delivery strategies can mitigate risks while preserving therapeutic efficacy in precision medicine.